BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,461,581 | +0.7% | 924,720 | +0.0% | 0.02% | +5.3% |
| Q2 2023 | $99,800,708 | -42.4% | 924,680 | -33.5% | 0.02% | -47.2% |
| Q1 2023 | $173,229,880 | -44.2% | 1,390,728 | -32.8% | 0.04% | -45.5% |
| Q4 2022 | $310,710,410 | +41.8% | 2,068,248 | +27.3% | 0.07% | +34.7% |
| Q3 2022 | $219,126,000 | +97.5% | 1,624,662 | +118.2% | 0.05% | +104.2% |
| Q2 2022 | $110,956,000 | -12.6% | 744,483 | +0.0% | 0.02% | +9.1% |
| Q1 2022 | $126,978,000 | -74.0% | 744,322 | -60.8% | 0.02% | -71.4% |
| Q4 2021 | $488,886,000 | -38.5% | 1,896,398 | -34.9% | 0.08% | -43.4% |
| Q3 2021 | $794,673,000 | +4.2% | 2,910,942 | -14.5% | 0.14% | +4.6% |
| Q2 2021 | $762,614,000 | +1513.5% | 3,406,350 | +686.9% | 0.13% | +1344.4% |
| Q1 2021 | $47,266,000 | – | 432,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |